Second-line hormonotherapy for breast cancer. Uselessness of first-line continuation.
Pronzato P, Rubagotti A, Amoroso D, Bertelli G, Queirolo P, Sertoli MR, Rosso M, Gallotti P, Monzeglio C, Rosso R.
Pronzato P, et al. Among authors: rosso m, rosso r.
Am J Clin Oncol. 1993 Dec;16(6):522-5. doi: 10.1097/00000421-199312000-00013.
Am J Clin Oncol. 1993.
PMID: 8256770
Clinical Trial.